Immunometabolism and mitochondria in inflammatory bowel disease: a role for therapeutic intervention?
Disease Models & Mechanisms · 01.10.2024 · 17 (10)
DOI: 10.1242/dmm.050895 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Disease Models & Mechanisms, online erschienen am 17.10.2024. Verfasst von Claire E Adams und 3 weiteren Autor:innen. Beteiligte Einrichtung: Gut Research Unit, Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh EH16 4UU, UK. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Mitochondria. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Leona M. and Harry B. Helmsley Charitable Trust, Chief Scientist Office, Scottish Government Health and Social Care Directorate.
Abstract (Originalsprache)
Inflammatory bowel diseases (IBDs), incurable conditions characterised by recurrent episodes of immune-mediated gut inflammation and damage of unknown aetiology, are common. Current advanced therapies target key leukocyte-trafficking and cytokine-signalling hubs but are only effective in 50% of patients. With growing evidence of mitochondrial dysfunction in IBD and advances in our understanding of the role of metabolism in inflammation, we provide an overview of novel metabolic approaches to IBD therapy, challenging the current ‘therapeutic ceiling’, identifying critical pathways for intervention and re-imagining metabolic biomarkers for the 21st century.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Gut Research Unit, Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh EH16 4UU, UK.
ORCID-Profile: Gwo-Tzer Ho
Förderung
- Wellcome Trust
- Leona M. and Harry B. Helmsley Charitable Trust
- Chief Scientist Office, Scottish Government Health and Social Care Directorate
Zitieren
APA
Adams, C. E., Rutherford, D. G., Jones, G. R., & Ho, G. T. (2024). Immunometabolism and mitochondria in inflammatory bowel disease: a role for therapeutic intervention?. Disease Models & Mechanisms, 17(10). https://doi.org/10.1242/dmm.050895
Vancouver
Adams CE, Rutherford DG, Jones GR, Ho GT. Immunometabolism and mitochondria in inflammatory bowel disease: a role for therapeutic intervention?. Disease Models & Mechanisms. 2024;17(10). doi:10.1242/dmm.050895
BibTeX
@article{Adams2024,
author = {Adams, Claire E and Rutherford, Duncan G and Jones, Gareth R and Ho, Gwo-Tzer},
title = {Immunometabolism and mitochondria in inflammatory bowel disease: a role for therapeutic intervention?},
journal = {Disease Models & Mechanisms},
year = {2024},
volume = {17},
number = {10},
doi = {10.1242/dmm.050895}
}
EUVIMED